| Literature DB >> 31838876 |
Sreedhar Adapa1, Srikanth Naramala2, Bhaskar Reddy Madhira3, Vijay Gayam4, Prem Sahasranam5, Venu Madhav Konala6.
Abstract
Peritonitis caused by gram-negative organisms is a significant complication encountered in patients undergoing peritoneal dialysis and is associated with high morbidity and mortality. There has been recognition of peritonitis caused by uncommon organisms because of improved microbiological detection techniques. In this article, we report a rare case of peritonitis caused by Pasteurella multocida. We present a 58-year-old male on peritoneal dialysis with fever and abdominal pain. The peritoneal fluid was cloudy, and the analysis was consistent with peritonitis. The peritoneal fluid culture grew Pasteurella multocida. The patient was treated with a 3-week course of intraperitoneal ceftazidime, which resulted in the resolution of infection with the salvation of the peritoneal dialysis catheter. Patient education plays a very critical role in the prevention of peritonitis from Pasteurella multocida, particularly if patients have pets at home. The domestic pets should be kept away from the dialysis equipment and should not be allowed into the room during dialysis treatment. Incorporating the education in handing pets during the training session is the key aspect.Entities:
Keywords: Pasteurella multocida; cats; gram-negative coccobacilli; peritoneal dialysis; peritonitis
Year: 2019 PMID: 31838876 PMCID: PMC6913050 DOI: 10.1177/2324709619895165
Source DB: PubMed Journal: J Investig Med High Impact Case Rep ISSN: 2324-7096
Sensitivities of Pasteurella multocida.
| Antibiotic | Minimum Inhibitory Concentration | Sensitivity Result (S = Sensitive, R = Resistant) |
|---|---|---|
| Ampicillin | 0.5 µg/mL | S |
| Ceftazidime | ≤0.03 µg/mL | S |
| Chloramphenicol | 1 µg/mL | S |
| Levofloxacin | <0.03 µg/mL | S |
| Penicillin | 0.25 µg/mL | S |
| Trimethoprim/sulfamethoxazole | 0.25/4.75 µg/mL | S |
Summary of All the Cases Listed as Pasteurella multocida Peritonitis With Patients on Dialysis as per PubMed Review of Literature.
| Author | Year | Age/Gender | Duration (Months) | Dialysis Mode | Leakage | Dialysate Culture | Animal Exposure | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| Paul and Rostand[ | 1987 | 55/female | 4 | CCPD | Present | Positive | Cat bite/scratch | Gentamicin | Improved |
| Frankel and Cassidy[ | 1991 | 55/male | 15 | CAPD | Absent | Positive | Cat exposure | Gentamicin, ciprofloxacin | Improved |
| London and Bottone[ | 1991 | 54/male | 6 | CCPD | Present | Positive | Cat bite | Cefazolin, gentamicin | Improved |
| Elsey et al[ | 1991 | 25/male | ≤24 | CCPD | Absent | Positive | Cat exposure | Cephradine, gentamicin | Improved |
| Kitching et al[ | 1996 | 75/male | 6 | CAPD | Present | Positive | Cat bite | Cefamandole | Improved |
| Uribarri et al[ | 1996 | 42/female | 108 | CCPD | Present | Positive | Cat bite | Penicillin, gentamicin | Improved |
| Loghman-Adham[ | 1997 | 12/female | 7 | CCPD | Present | Positive | Cat bite | Cephapirin, gentamicin | Improved |
| Mackay et al[ | 1997 | 73/male | 12 | CAPD | Absent | Positive | Cat exposure | Ceftazidime | Improved |
| Joh et al[ | 1998 | 55/male | 12 | CCPD | Present | Positive | Cat bite | Ampicillin/sulbactam, gentamicin | Improved |
| Musio and Tiu[ | 1998 | 46/female | 7 | CCPD | Absent | Positive | Cat exposure | Piperacillin, ciprofloxacin | Improved |
| Hamai et al[ | 1999 | 49/male | 4 | CCPD | Present | Positive | Cat exposure | Cefazolin, tobramicin | Improved |
| Chadha and Warady[ | 1999 | 16/male | 60 | CCPD | Present | Positive | Cat bite | Ticarcillin, tobramicin | |
| Van Langenhove et al[ | 2000 | 22/female | 12 | CCPD | Present | Positive | Cat scratch | Amikacin, ciprofloxacin | Improved |
| Martinez et al[ | 2000 | 46/female | NA | CCPD | NA | Positive | NA | Ceftazidime | NA |
| Kanaan et al[ | 2002 | 24/female | 7 | CCPD | Absent | Positive | Cat exposure | Ciprofloxacin | Improved |
| Sillery et al[ | 2004 | 48/female | 36 | CAPD | Absent | Positive | Cat exposure | Cefazolin, gentamicin, ampicillin | Improved |
| Cooke et al[ | 2004 | 73/female | 8 and 12 | CAPD | Present | Positive | Cat bite | Gentamicin, ciprofloxacin | Improved |
| Mat et al[ | 2005 | 52/male | 3 | CCPD | Present | Positive | Cat exposure | Cefazolin, amikacin | Improved |
| Malik et al[ | 2005 | 21/female | 36 | CCPD | Present | Positive | Cat bite | Gentamicin, cefazolin piperacillin/tazobactam | Improved |
| Malik et al[ | 2005 | 58/male | 12 | CCPD | Present | Positive | Cat bite | Gentamicin | Improved |
| Olea et al[ | 2006 | 46/female | 24 | CCPD | Absent | Positive | Cat exposure | Ceftazidime | Improved, catheter removed |
| Antony and Oglesby[ | 2007 | 48/female | NA | CAPD | Absent | Positive | Dog exposure | Cefazolin, gentamicin | Improved |
| Rondon-Berrios and Trevejo-Nunez[ | 2010 | 38/male | 60 | CCPD | Present | Positive | Cat exposure | Piperacillin/tazobactam, ampicillin, levofloxacin | Improved, catheter removed |
| Mugambi and Ullian[ | 2010 | 36/female | NA | CCPD | Absent | Positive | Cat exposure | Gentamicin, ciprofloxacin | Improved, catheter removed |
| Satomura et al[ | 2010 | 58/male | CCPD | Absent | Positive | Cat exposure | Cefazolin, levofloxacin | Improved | |
| Nishina et al[ | 2011 | 45/male | 84 | CCPD | Present | Positive | Cat exposure | Ceftazidime, levofloxacin | Improved |
| Weiss and Panesar[ | 2012 | 57/male | 1 | CAPD | Absent | positive | Cat and dog exposure | Vancomycin, ceftazidime | Improved |
| Sol et al[ | 2013 | 7/female | 24 | NIPD | Present | Positive | Cat exposure | Ampicillin | Improved |
| Kim et al[ | 2014 | 25/female | 24 | CAPD | Absent | Positive | Cat exposure | Cefazolin, gentamicin | Improved |
| Dresselaars et al[ | 2014 | 62/female | 37 | CAPD | Absent | Positive | Cat exposure | Cefalothin, ciprofloxacin | Improved |
| Poliquin et al[ | 2015 | 28/female | 1 | CAPD | Present | Positive | Cat bite | Ceftazidime | Improved |
| Poliquin et al[ | 2015 | 37/male | 15 | CAPD | Absent | Positive | Cat bite | Cefazolin | Improved |
| Poliquin et al[ | 2015 | 41/male | 18 | CAPD | NA | Positive | Cat bite | Cefazolin | Improved |
| Poliquin et al[ | 2015 | 51/female | 7 | CAPD | Absent | Positive | Cat exposure | Amoxicillin-clavulanic acid | Improved |
| Poliquin et al[ | 2015 | 37/female | 132 | CAPD | Absent | Positive | Cat exposure | Ceftriaxone, amoxicillin | Improved, catheter removed |
| Poliquin et al[ | 2015 | 59/female | 36 | CAPD | Absent | Positive | Cat exposure | Ceftazidime | Improved |
| Poliquin et al[ | 2015 | 69/female | 1 | CAPD | NA | Positive | Cat bite | Ceftazidime | Improved |
| Giron et al[ | 2017 | 72/male | 24 | CCPD | Present | Positive | Cat bit | Ceftazidime | Improved |
Abbreviations: CCPD, continuous cyclic peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; NA, not available; NIPD, nocturnal intermittent peritoneal dialysis.